Safety Study of a Liposomal Docetaxel Formulation in Patients With Solid Tumors Who Have Failed Previous Therapies

Clinical trial NCT01041235 · COMPLETED

Trial details

NCT number: NCT01041235
Sponsor: Azaya Therapeutics, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumor Breast Cancer Ovarian Cancer Pancreatic Cancer Non-Small Cell Lung

Start date: 2009-12-01
Primary completion: 2011-10-01
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.